Medicine shortages

gaps between countries and global perspectives

Angela Acosta, Egdda Patricia Vanegas, Joan Rovira, Brian Godman, Tomasz Bochenek

Research output: Contribution to journalArticle

3 Downloads (Pure)

Abstract

Introduction Over the last decade, global health policies and different research areas have focused on the relevance and impact of medicine shortages. Published studies suggest there have been difficulties with access to medicines since the beginning of the twentieth century. There have though been advances in our understanding and management of the problem. However, in view of global and regional health care concerns with shortages, we believe this phenomenon needs to be characterized and described more fully. This includes the types of medicines affected, possible causes, and potential strategies to address these. The aim of this scoping review was to identify, compare if possible, and characterize the recent literature about the situation of medicines shortages between countries, and provide different perspectives including a global context and national approaches to help address the situation. 
Methodology A scoping study presented as a narrative review of the situation and findings principally based on published papers. 
Results Based on the reported cases in the literature, a typology of medicines shortage and supply interruption episodes and their causes were proposed. National approaches to notify and manage the medicines shortages cases were described and classified by update frequency. In addition, principal differences between market and supply chain management perspectives of the situation were identified and global and countries’ perspectives were described. 
Conclusion Policy makers require solutions that prevent those cases in which the population's health is affected by episodes of medicine shortages and/or interruption in the supply chain. There is also a need to generate a glossary related to logistics management and the availability of medicines. This will be useful to understand and overcome shortages as well as recognize that potential solutions are not only related with actions linked to research, development and innovation but much wider. Overall, this paper can act as a basis for future discussions in this important area.
Original languageEnglish
Article number763
Number of pages21
JournalFrontiers in Pharmacology
Volume10
DOIs
Publication statusPublished - 19 Jul 2019

Fingerprint

Medicine
Health Policy
Research
Delivery of Health Care
Health
Population
Global Health

Keywords

  • medicine shortages
  • medicine access
  • pharmaceutical policy
  • medicine supply
  • South America
  • Europe
  • North America
  • Western Asia

Cite this

Acosta, Angela ; Vanegas, Egdda Patricia ; Rovira, Joan ; Godman, Brian ; Bochenek , Tomasz. / Medicine shortages : gaps between countries and global perspectives. In: Frontiers in Pharmacology . 2019 ; Vol. 10.
@article{ae42f1c043324a65af8bda1ad3f87520,
title = "Medicine shortages: gaps between countries and global perspectives",
abstract = "Introduction Over the last decade, global health policies and different research areas have focused on the relevance and impact of medicine shortages. Published studies suggest there have been difficulties with access to medicines since the beginning of the twentieth century. There have though been advances in our understanding and management of the problem. However, in view of global and regional health care concerns with shortages, we believe this phenomenon needs to be characterized and described more fully. This includes the types of medicines affected, possible causes, and potential strategies to address these. The aim of this scoping review was to identify, compare if possible, and characterize the recent literature about the situation of medicines shortages between countries, and provide different perspectives including a global context and national approaches to help address the situation. Methodology A scoping study presented as a narrative review of the situation and findings principally based on published papers. Results Based on the reported cases in the literature, a typology of medicines shortage and supply interruption episodes and their causes were proposed. National approaches to notify and manage the medicines shortages cases were described and classified by update frequency. In addition, principal differences between market and supply chain management perspectives of the situation were identified and global and countries’ perspectives were described. Conclusion Policy makers require solutions that prevent those cases in which the population's health is affected by episodes of medicine shortages and/or interruption in the supply chain. There is also a need to generate a glossary related to logistics management and the availability of medicines. This will be useful to understand and overcome shortages as well as recognize that potential solutions are not only related with actions linked to research, development and innovation but much wider. Overall, this paper can act as a basis for future discussions in this important area.",
keywords = "medicine shortages, medicine access, pharmaceutical policy, medicine supply, South America, Europe, North America, Western Asia",
author = "Angela Acosta and Vanegas, {Egdda Patricia} and Joan Rovira and Brian Godman and Tomasz Bochenek",
year = "2019",
month = "7",
day = "19",
doi = "10.3389/fphar.2019.00763",
language = "English",
volume = "10",
journal = "Frontiers in Pharmacology",
issn = "1663-9812",

}

Medicine shortages : gaps between countries and global perspectives. / Acosta, Angela; Vanegas, Egdda Patricia ; Rovira, Joan; Godman, Brian; Bochenek , Tomasz.

In: Frontiers in Pharmacology , Vol. 10, 763, 19.07.2019.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Medicine shortages

T2 - gaps between countries and global perspectives

AU - Acosta, Angela

AU - Vanegas, Egdda Patricia

AU - Rovira, Joan

AU - Godman, Brian

AU - Bochenek , Tomasz

PY - 2019/7/19

Y1 - 2019/7/19

N2 - Introduction Over the last decade, global health policies and different research areas have focused on the relevance and impact of medicine shortages. Published studies suggest there have been difficulties with access to medicines since the beginning of the twentieth century. There have though been advances in our understanding and management of the problem. However, in view of global and regional health care concerns with shortages, we believe this phenomenon needs to be characterized and described more fully. This includes the types of medicines affected, possible causes, and potential strategies to address these. The aim of this scoping review was to identify, compare if possible, and characterize the recent literature about the situation of medicines shortages between countries, and provide different perspectives including a global context and national approaches to help address the situation. Methodology A scoping study presented as a narrative review of the situation and findings principally based on published papers. Results Based on the reported cases in the literature, a typology of medicines shortage and supply interruption episodes and their causes were proposed. National approaches to notify and manage the medicines shortages cases were described and classified by update frequency. In addition, principal differences between market and supply chain management perspectives of the situation were identified and global and countries’ perspectives were described. Conclusion Policy makers require solutions that prevent those cases in which the population's health is affected by episodes of medicine shortages and/or interruption in the supply chain. There is also a need to generate a glossary related to logistics management and the availability of medicines. This will be useful to understand and overcome shortages as well as recognize that potential solutions are not only related with actions linked to research, development and innovation but much wider. Overall, this paper can act as a basis for future discussions in this important area.

AB - Introduction Over the last decade, global health policies and different research areas have focused on the relevance and impact of medicine shortages. Published studies suggest there have been difficulties with access to medicines since the beginning of the twentieth century. There have though been advances in our understanding and management of the problem. However, in view of global and regional health care concerns with shortages, we believe this phenomenon needs to be characterized and described more fully. This includes the types of medicines affected, possible causes, and potential strategies to address these. The aim of this scoping review was to identify, compare if possible, and characterize the recent literature about the situation of medicines shortages between countries, and provide different perspectives including a global context and national approaches to help address the situation. Methodology A scoping study presented as a narrative review of the situation and findings principally based on published papers. Results Based on the reported cases in the literature, a typology of medicines shortage and supply interruption episodes and their causes were proposed. National approaches to notify and manage the medicines shortages cases were described and classified by update frequency. In addition, principal differences between market and supply chain management perspectives of the situation were identified and global and countries’ perspectives were described. Conclusion Policy makers require solutions that prevent those cases in which the population's health is affected by episodes of medicine shortages and/or interruption in the supply chain. There is also a need to generate a glossary related to logistics management and the availability of medicines. This will be useful to understand and overcome shortages as well as recognize that potential solutions are not only related with actions linked to research, development and innovation but much wider. Overall, this paper can act as a basis for future discussions in this important area.

KW - medicine shortages

KW - medicine access

KW - pharmaceutical policy

KW - medicine supply

KW - South America

KW - Europe

KW - North America

KW - Western Asia

U2 - 10.3389/fphar.2019.00763

DO - 10.3389/fphar.2019.00763

M3 - Article

VL - 10

JO - Frontiers in Pharmacology

JF - Frontiers in Pharmacology

SN - 1663-9812

M1 - 763

ER -